Tennessee Senate Bill SB2242

Tennessee 2025-2026 Regular Session

• Introduced: 2/2/26

Caption

AN ACT to amend Tennessee Code Annotated, Title 33; Title 53; Title 63; Title 68 and Title 71, relative to pharmacies.

Summary

SB2242 makes a narrow change to Tennessee pharmacy law by amending Tennessee Code Annotated section 63-10-222. The bill changes a statutory deadline from April 15 to October 15. Based on the caption and the single text amendment, the measure appears to adjust a filing, reporting, or compliance date within the pharmacy regulatory framework rather than creating a new program or broad policy change. The bill’s impact on state law is limited but direct: it updates one date in the pharmacy statutes and leaves the rest of the referenced titles unchanged. Because the act takes effect immediately upon becoming law, any affected pharmacies, licensees, or regulated entities would need to follow the new October 15 deadline instead of the prior April 15 deadline. The bill does not appear to alter substantive licensing standards, enforcement powers, or patient-facing pharmacy rules beyond that timing change. The general sentiment around the bill appears favorable. In the Senate Health and Welfare Committee, it was recommended for passage with amendments by an 8-1 vote, indicating broad support with only limited opposition. The lack of recorded transcript discussion suggests the measure was not especially controversial and was treated as a technical or administrative update. The main point of contention, to the extent one exists, is the shift in deadline itself and whether moving the date from April to October better aligns with regulatory or operational needs. The single dissenting vote suggests at least one member had reservations, but no specific objections are provided in the available record. Overall, the bill seems to have been viewed as a modest housekeeping change affecting pharmacy compliance timing rather than a major policy dispute.

Impact

SB2242 amends Tennessee Code Annotated section 63-10-222 by changing a statutory deadline from April 15 to October 15. This updates the timing requirement for the affected pharmacy-related provision and may change when regulated parties must file, report, or otherwise comply with the statute. The bill does not appear to revise broader pharmacy licensing, disciplinary, or operational rules, but it does directly alter the compliance schedule in state law.

Sentiment

The available legislative history suggests generally positive sentiment toward the bill. The Senate Health and Welfare Committee recommended passage with amendments by an 8-1 vote, which indicates substantial support and only limited opposition. No committee transcript is available, so the record does not show detailed debate, but the vote pattern suggests the measure was viewed as a routine or technical adjustment rather than a controversial policy change.

Contention

The only apparent point of contention is the change in deadline from April 15 to October 15, which may affect regulated pharmacy entities’ compliance timing. One committee member voted against the measure, but no explanation is provided in the available materials. Because there are no transcripts, it is not possible to identify whether the concern involved administrative burden, implementation timing, or some other issue. Overall, the bill does not show evidence of broader disagreement over pharmacy policy.